ENTA - ENANTA PHARMACEUTICALS INC

QQQ $ 479.98 $ -2.50 (-0.52 %)

DIA $ 391.11 $ -0.43 (-0.11 %)

SPY $ 544.70 $ -2.15 (-0.39 %)

TLT $ 91.77 $ -1.74 (-1.86 %)

GLD $ 215.03 $ 0.02 (0.01 %)

Previous Close

$ 12.97

Open

$ 12.91

Bid

$ 12.86 x 200

Ask

$ 0.00 x 0

Day's Range

$ 11.95 - $ 13.02

52 Week Range

$ 8.08 - $ 22.15

Volume

354,695

Average Volume

Market Cap

274.54M

Beta (5Y Monthly)

$ 0.68

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	02-08-2024	12-31-2023	10-Q
3	11-22-2023	09-30-2023	10-K
4	08-08-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	02-08-2023	12-31-2022	10-Q
7	11-23-2022	09-30-2022	10-K
8	08-08-2022	06-30-2022	10-Q
9	05-09-2022	03-31-2022	10-Q
10	02-10-2022	12-31-2021	10-Q
11	11-24-2021	09-30-2021	10-K
12	08-09-2021	06-30-2021	10-Q
13	05-10-2021	03-31-2021	10-Q
14	02-09-2021	12-31-2020	10-Q
15	11-25-2020	09-30-2020	10-K
16	08-10-2020	06-30-2020	10-Q
17	05-11-2020	03-31-2020	10-Q
18	02-10-2020	12-31-2019	10-Q
19	11-27-2019	09-30-2019	10-K
20	08-09-2019	06-30-2019	10-Q
21	05-10-2019	03-31-2019	10-Q
22	02-08-2019	12-31-2018	10-Q
23	11-29-2018	09-30-2018	10-K
24	08-09-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	02-09-2018	12-31-2017	10-Q
27	12-11-2017	09-30-2017	10-K
28	08-09-2017	06-30-2017	10-Q
29	05-10-2017	03-31-2017	10-Q
30	02-09-2017	12-31-2016	10-Q
31	12-09-2016	09-30-2016	10-K
32	08-09-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	02-09-2016	12-31-2015	10-Q
35	12-11-2015	09-30-2015	10-K
36	08-10-2015	06-30-2015	10-Q
37	05-08-2015	03-31-2015	10-Q
38	02-06-2015	12-31-2014	10-Q
39	12-11-2014	09-30-2014	10-K
40	08-12-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Enant...
05/07/2024 17:47:42

HC Wainwright & Co. analyst Ed Arce maintains Enanta Pharma (NASDAQ:ENTA) with a Buy and lowers the price target from $2...

JMP Securities Maintains Market Outperform...
05/07/2024 15:34:16

JMP Securities analyst Roy Buchanan maintains Enanta Pharma (NASDAQ:ENTA) with a Market Outperform and lowers the price targ...

Enanta Pharma Q2 2024 GAAP EPS $(1.47) Mis...
05/06/2024 20:05:27

Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(1.47) per share which missed the analyst consensus estimate of $(1.3...

JP Morgan Maintains Underweight on Enanta ...
02/08/2024 21:43:44

JP Morgan analyst Eric Joseph maintains Enanta Pharma (NASDAQ:ENTA) with a Underweight and lowers the price target from $12 ...

Recap: Enanta Pharma Q1 Earnings
02/07/2024 21:15:14

Enanta Pharma Q1 2024 GAAP EPS $(1.58) Mis...
02/07/2024 21:14:41

Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(1.58) per share which missed the analyst consensus estimate of $(1.2...

Earnings Scheduled For February 7, 2024
02/07/2024 10:13:28

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per shar...

Earnings Preview For Enanta Pharma
02/06/2024 18:02:16

Enanta Pharmaceuticals Will Provide An Upd...
01/04/2024 12:07:18

Expansion into Immunology with New Discovery Program of Oral KIT Inhibitors Addressing High Unmet Need in Chronic Spontaneous...

Oppenheimer Maintains Perform on Enanta Ph...
11/22/2023 18:47:48

Oppenheimer analyst Jay Olson maintains Enanta Pharma (NASDAQ:ENTA) with a Perform and lowers the price target from $25 to $21.

Why American Eagle Shares Are Trading Lowe...
11/21/2023 18:28:06

Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarte...

What 5 Analyst Ratings Have To Say About E...
11/21/2023 14:00:18

HC Wainwright & Co. Maintains Buy on Enant...
11/21/2023 11:53:17

HC Wainwright & Co. analyst Ed Arce maintains Enanta Pharma (NASDAQ:ENTA) with a Buy and lowers the price target from $3...

JMP Securities Maintains Outperform on Ena...
11/21/2023 11:51:14

JMP Securities analyst Roy Buchanan maintains Enanta Pharma (NASDAQ:ENTA) with a Outperform and lowers the price target from...

Recap: Enanta Pharma Q4 Earnings
11/20/2023 21:15:18

Enanta Pharma Q4 EPS $(1.33) Vs. $(1.27) L...
11/20/2023 21:03:39

Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(1.33) per share. This is a 4.72 percent decrease over losses of $(1....

Earnings Scheduled For November 20, 2023
11/20/2023 12:11:31

Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 ...

Enanta Pharma Earnings Preview
11/17/2023 14:01:34

Analyst Expectations for Enanta Pharma's F...
10/23/2023 16:00:32

HC Wainwright & Co. Maintains Buy on Enant...
10/23/2023 11:07:31

HC Wainwright & Co. analyst Ed Arce maintains Enanta Pharma (NASDAQ:ENTA) with a Buy and lowers the price target from $4...

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)

ENTAENANTA PHARMACEUTICALS INC

Nasdaq enanta.com

$ 12.95 $ 0.30 (2.37 %)

Friday, 28-Jun-2024 15:59:56 EDT